Literature DB >> 18498077

EPH receptors in cancer.

Julio Castaño1, Veronica Davalos, Simo Schwartz, Diego Arango.   

Abstract

EPH receptors and their ephrin ligands constitute the largest sub-family of receptor tyrosine kinases (RTKs) and are components of cell signaling pathways involved in animal development. The ability of the EPH/ephrin guidance system to position cells and modulate cell morphology underlies their various roles in development. In addition, EPH signaling plays an important role in oncogenic processes observed in several organs. These receptors are involved in a wide range of processes directly related with tumorigenesis and metastasis, including cell attachment and shape, migration, and angiogenesis. Accordingly, deregulation of EPH expression and signaling activity could be crucial for the tumorigenic process. This review focuses on EPH receptors' roles in oncogenic transformation and tumor progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18498077     DOI: 10.14670/HH-23.1011

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  22 in total

1.  Eph/ephrin interactions modulate muscle satellite cell motility and patterning.

Authors:  Danny A Stark; Rowan M Karvas; Ashley L Siegel; D D W Cornelison
Journal:  Development       Date:  2011-11-09       Impact factor: 6.868

2.  Ephrin receptor (Eph) -A1, -A2, -A4 and -A7 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.

Authors:  Stamatios Theocharis; Jerzy Klijanienko; Constantinos Giaginis; Paraskevi Alexandrou; Efstratios Patsouris; Xavier Sastre-Garau
Journal:  Pathol Oncol Res       Date:  2013-09-11       Impact factor: 3.201

Review 3.  Eph receptors and ephrins in cancer: bidirectional signalling and beyond.

Authors:  Elena B Pasquale
Journal:  Nat Rev Cancer       Date:  2010-03       Impact factor: 60.716

Review 4.  Eph- and ephrin-dependent mechanisms in tumor and stem cell dynamics.

Authors:  Erika Gucciardo; Nami Sugiyama; Kaisa Lehti
Journal:  Cell Mol Life Sci       Date:  2014-05-04       Impact factor: 9.261

5.  Cancer somatic mutations disrupt functions of the EphA3 receptor tyrosine kinase through multiple mechanisms.

Authors:  Erika M Lisabeth; Carlos Fernandez; Elena B Pasquale
Journal:  Biochemistry       Date:  2012-02-08       Impact factor: 3.162

6.  Genomic characterization of gene copy-number aberrations in endometrial carcinoma cell lines derived from endometrioid-type endometrial adenocarcinoma.

Authors:  Yingmei Wang; Da Yang; David Cogdell; Limei Hu; Fengxia Xue; Russell Broaddus; Wei Zhang
Journal:  Technol Cancer Res Treat       Date:  2010-04

Review 7.  Non-SH2/PDZ reverse signaling by ephrins.

Authors:  Ira O Daar
Journal:  Semin Cell Dev Biol       Date:  2011-10-21       Impact factor: 7.727

8.  Clinical significance of ephrin (eph)-A1, -A2, -a4, -a5 and -a7 receptors in pancreatic ductal adenocarcinoma.

Authors:  Constantinos Giaginis; Gerasimos Tsourouflis; Adamantia Zizi-Serbetzoglou; Gregorios Kouraklis; Elli Chatzopoulou; Konstantina Dimakopoulou; Stamatios E Theocharis
Journal:  Pathol Oncol Res       Date:  2009-12-01       Impact factor: 3.201

9.  Clinical Significance of EphB4 and EphB6 Expression in Human Malignant and Benign Thyroid Lesions.

Authors:  Constantinos Giaginis; Paraskevi Alexandrou; Elpida Poulaki; Ioanna Delladetsima; Constantinos Troungos; Efstratios Patsouris; Stamatios Theocharis
Journal:  Pathol Oncol Res       Date:  2015-07-30       Impact factor: 3.201

10.  EphrinB1 interacts with CNK1 and promotes cell migration through c-Jun N-terminal kinase (JNK) activation.

Authors:  Hee Jun Cho; Yoo-Seok Hwang; Kathleen Mood; Yon Ju Ji; Junghwa Lim; Deborah K Morrison; Ira O Daar
Journal:  J Biol Chem       Date:  2014-05-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.